237
Views
16
CrossRef citations to date
0
Altmetric
Articles

SEVERE HEMORRHAGIC COLITIS CAUSED BY DASATINIB IN PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA

, , , , , , , , , , & show all
Pages 448-453 | Accepted 22 May 2009, Published online: 11 Nov 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Devin B Lowe, Anamika Bose, Jennifer L Taylor, Hussein Tawbi, Yan Lin, John M Kirkwood & Walter J Storkus. (2014) Dasatinib promotes the expansion of a therapeutically superior T-cell repertoire in response to dendritic cell vaccination against melanoma. OncoImmunology 3:2.
Read now
Kirk R Schultz, Tim Prestidge & Bruce Camitta. (2010) Philadelphia chromosome-positive acute lymphoblastic leukemia in children: new and emerging treatment options. Expert Review of Hematology 3:6, pages 731-742.
Read now

Articles from other publishers (13)

Aoife McCarthy & Kieran Sheahan. 2020. Non-Neoplastic Pathology of the Gastrointestinal Tract. Non-Neoplastic Pathology of the Gastrointestinal Tract 65 83 .
. 2020. Non-Neoplastic Pathology of the Gastrointestinal Tract. Non-Neoplastic Pathology of the Gastrointestinal Tract.
Xin Liao, Yuxia Guo, Yali Shen & Jianwen Xiao. (2020) Recurrent Gastrointestinal Hemorrhage in Children with Philadelphia-Positive B-Cell Acute Lymphoblastic Leukemia Treated with Dasatinib: Case Reports. Case Reports in Hematology 2020, pages 1-5.
Crossref
Esra Terzi Demirsoy, Ozgur Mehtap, Elif Birtas Atesoglu, Pinar Tarkun, Necmi Eren, Ayfer Gedük & Abdullah Hacihanefioglu. (2018) Dasatinib-induced immune mediated-thrombotic thrombocytopenic purpura. Transfusion and Apheresis Science 57:2, pages 222-224.
Crossref
Ibrahim Aldoss, Karl Gaal, Monzr M. Al Malki, Haris Ali, Ryotaro Nakamura, Stephen J. Forman & Vinod Pullarkat. (2016) Dasatinib-Induced Colitis after Allogeneic Stem Cell Transplantation for Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia. Biology of Blood and Marrow Transplantation 22:10, pages 1900-1903.
Crossref
Güray Can, Süleyman Ayvaz, Hatice Can, İhsan Karaboğa, Selim Demirtaş, Hasan Akşit, Bülent Yılmaz, Uğur Korkmaz, Mevlüt Kurt & Turan Karaca. (2016) The efficacy of tyrosine kinase inhibitor dasatinib on colonic mucosal damage in murine model of colitis. Clinics and Research in Hepatology and Gastroenterology 40:4, pages 504-516.
Crossref
Fidencio Davalos, Benjamin Chaucer, Wahib Zafar, Shamim Salman & Jay Nfonoyim. (2016) Dasatinib-Induced CMV Hepatitis in an Immunocompetent Patient: A Rare Complication of a Common Drug. Translational Oncology 9:3, pages 248-250.
Crossref
Hongkeun Ahn, Ji Eun Kwon, Seong-Wook Sohn, Ji-Hyun Kwon, Joo Sung Kim, Sung-Soo Yoon, Hye-Ryun Kang & Kyoung Sup Hong. (2015) A Case of Dasatinib-Induced Hemorrhagic Colitis Diagnosed by the Lymphocyte Transformation Test in a Chronic Myeloid Leukemia Patient. Indian Journal of Hematology and Blood Transfusion 32:S1, pages 96-99.
Crossref
Mohamed Shanshal, Andrew Shakespeare, Seshadri Thirumala, Boyd Fenton & Donald P. Quick. (2016) Dasatinib-Induced T-Cell-Mediated Colitis: A Case Report and Review of the Literature. Acta Haematologica 136:4, pages 219-228.
Crossref
Morgan E. Roberts, Jennifer L. Bishop, Xueling Fan, Jennifer L. Beer, Winnie W. S. Kum, Danielle L. Krebs, Morris Huang, Navkiran Gill, John J. Priatel, B. Brett Finlay & Kenneth W. Harder. (2014) Lyn Deficiency Leads to Increased Microbiota-Dependent Intestinal Inflammation and Susceptibility to Enteric Pathogens. The Journal of Immunology 193:10, pages 5249-5263.
Crossref
J L Bishop, M E Roberts, J L Beer, M Huang, M K Chehal, X Fan, L A Fouser, H L Ma, J T Bacani & K W Harder. (2014) Lyn activity protects mice from DSS colitis and regulates the production of IL-22 from innate lymphoid cells. Mucosal Immunology 7:2, pages 405-416.
Crossref
Meinolf Suttorp, Isaac Yaniv & Kirk R. Schultz. (2011) Controversies in the Treatment of CML in Children and Adolescents: TKIs versus BMT?. Biology of Blood and Marrow Transplantation 17:1, pages S115-S122.
Crossref
. (2010) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 19:2.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.